Mind Medicine (MindMed) Inc.

NasdaqGS MNMD

Mind Medicine (MindMed) Inc. Capital Expenditure for the year ending December 31, 2023: USD 0.00

Mind Medicine (MindMed) Inc. Capital Expenditure is USD 0.00 for the year ending December 31, 2023, a 0.00% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Mind Medicine (MindMed) Inc. Capital Expenditure for the year ending December 31, 2022 was USD 0.00, a 0.00% change year over year.
Mind Medicine (MindMed) Inc. Capital Expenditure for the year ending December 31, 2021 was USD 0.00, a 0.00% change year over year.
Mind Medicine (MindMed) Inc. Capital Expenditure for the year ending December 31, 2020 was USD 0.00, a 100.00% change year over year.
Mind Medicine (MindMed) Inc. Capital Expenditure for the year ending August 31, 2019 was USD -313.46 K, a 69.97% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

NasdaqGS: MNMD

Mind Medicine (MindMed) Inc.

CEO	Mr. Robert Barrow
IPO Date	Nov. 15, 2016
Location	Canada
Headquarters	1055 West Hastings Street
Employees	57
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Clinical Trials Drugstores & Retail Pharmacies Mental Health

Description

Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders related to psychiatry, addiction, pain, and neurology. The company develops MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder, as well as for the treatment of chronic pain; and MM-110, an a3ß4 nicotinic cholinergic receptor antagonist that has completed phase 1 for the treatment of opioid withdrawal. It also develops MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine for the treatment of core symptoms of autism spectrum disorder. The company is headquartered in Vancouver, Canada.

Key trends

Past 5 years